Earlier this year, Medgadget spoke with Noble International about the company’s self-injection trainers designed to mimic the patient experience with prefilled syringes and autoinjectors. During the interview, we heard about AdhereIT, “a smart attachable device component, available for various autoinjector form factors, that connects to the device and has the capability to track, monitor and guide patients not only through device training but also actual self-injections.”
Recently, Noble officially launched the “smart” AdhereIT platform, which includes features like detecting when the injection device makes contact with the injection site on the skin, injection scheduling reminders used in conjunction with an app, and wireless data transmission, including any administration errors, to a smartphone or tablet. Real-time feedback both during the training period and during injection is the cornerstone of AdhereIT’s innovative approach to improve self-injection adherence. A flexible form factor allows AdhereIT to be adapted to a variety of autoinjectors from various manufacturers.
Commenting on the announcement, Noble International CEO Jeff Baker said, “There has been a rapid growth of innovative treatments delivered through autoinjectors, which allow patients the convenience of self-administering the drug. Our priority is to help ensure that patients who self-inject feel confident they are using their devices correctly, since studies suggest device familiarity and patient confidence may help improve adherence. We believe our new connected error correcting device platform, with its array of smart features, can coach patients through training to administration at home.”